Paul Phillips
Concepts (290)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diplopia | 8 | 2024 | 20 | 2.380 |
Why?
| Exotropia | 7 | 2023 | 9 | 2.100 |
Why?
| Oculomotor Muscles | 5 | 2019 | 22 | 1.970 |
Why?
| Pseudotumor Cerebri | 7 | 2024 | 25 | 1.970 |
Why?
| Ocular Motility Disorders | 5 | 2018 | 17 | 1.920 |
Why?
| Ophthalmologic Surgical Procedures | 4 | 2019 | 21 | 1.850 |
Why?
| Vision, Low | 3 | 2022 | 9 | 1.670 |
Why?
| Optic Nerve | 6 | 2014 | 43 | 1.640 |
Why?
| Papilledema | 6 | 2025 | 27 | 1.510 |
Why?
| Optic Disk | 2 | 2023 | 20 | 1.380 |
Why?
| Intracranial Pressure | 5 | 2019 | 29 | 1.360 |
Why?
| Magnetic Resonance Imaging | 15 | 2023 | 1546 | 1.290 |
Why?
| Ophthalmology | 3 | 2025 | 33 | 1.250 |
Why?
| Hypopituitarism | 4 | 2014 | 16 | 1.220 |
Why?
| Eye Abnormalities | 4 | 2023 | 24 | 1.170 |
Why?
| Strabismus | 5 | 2019 | 15 | 1.110 |
Why?
| Child | 32 | 2025 | 7248 | 1.070 |
Why?
| Intracranial Hypertension | 3 | 2019 | 32 | 1.000 |
Why?
| Pituitary Gland | 3 | 2014 | 88 | 0.990 |
Why?
| Vision, Binocular | 4 | 2019 | 6 | 0.970 |
Why?
| Oculomotor Nerve Diseases | 2 | 2017 | 5 | 0.940 |
Why?
| Optic Nerve Diseases | 3 | 2023 | 23 | 0.930 |
Why?
| Humans | 71 | 2025 | 52483 | 0.870 |
Why?
| Vision Screening | 1 | 2022 | 11 | 0.790 |
Why?
| Fixation, Ocular | 3 | 2019 | 12 | 0.780 |
Why?
| Abducens Nerve Diseases | 2 | 2024 | 7 | 0.770 |
Why?
| Eye Diseases, Hereditary | 2 | 2017 | 5 | 0.740 |
Why?
| Tomography, Optical Coherence | 5 | 2022 | 109 | 0.720 |
Why?
| Dyslexia | 2 | 2018 | 41 | 0.700 |
Why?
| Distance Perception | 1 | 2019 | 3 | 0.660 |
Why?
| Child, Preschool | 21 | 2025 | 4076 | 0.630 |
Why?
| Postoperative Complications | 3 | 2015 | 1068 | 0.610 |
Why?
| Orthoptics | 1 | 2018 | 1 | 0.600 |
Why?
| Male | 37 | 2025 | 26761 | 0.600 |
Why?
| Vision Disorders | 3 | 2024 | 60 | 0.550 |
Why?
| Visual Acuity | 9 | 2022 | 144 | 0.540 |
Why?
| Apraxias | 3 | 2013 | 9 | 0.530 |
Why?
| Cavernous Sinus | 2 | 2011 | 15 | 0.530 |
Why?
| Female | 35 | 2025 | 28171 | 0.520 |
Why?
| Retinal Hemorrhage | 3 | 2023 | 13 | 0.500 |
Why?
| Eyeglasses | 3 | 2023 | 9 | 0.490 |
Why?
| Adolescent | 14 | 2024 | 6739 | 0.480 |
Why?
| Diagnosis, Differential | 9 | 2018 | 1046 | 0.470 |
Why?
| Nervous System Diseases | 2 | 2005 | 95 | 0.450 |
Why?
| Blindness | 3 | 2024 | 32 | 0.440 |
Why?
| Giant Cell Arteritis | 2 | 2025 | 15 | 0.420 |
Why?
| Comprehension | 2 | 2024 | 113 | 0.400 |
Why?
| Developmental Disabilities | 2 | 2013 | 122 | 0.400 |
Why?
| Infant | 12 | 2024 | 3733 | 0.400 |
Why?
| Meningitis, Cryptococcal | 1 | 2012 | 10 | 0.390 |
Why?
| Blepharoptosis | 1 | 2012 | 13 | 0.390 |
Why?
| Cryptococcus neoformans | 1 | 2012 | 26 | 0.380 |
Why?
| Internet | 2 | 2024 | 263 | 0.370 |
Why?
| Retinal Diseases | 2 | 2024 | 56 | 0.370 |
Why?
| Carotid Artery, Internal, Dissection | 1 | 2011 | 8 | 0.370 |
Why?
| Retrospective Studies | 12 | 2025 | 6607 | 0.370 |
Why?
| Brain Diseases | 2 | 2012 | 79 | 0.360 |
Why?
| Intracranial Aneurysm | 1 | 2011 | 44 | 0.360 |
Why?
| Tuberous Sclerosis | 1 | 2011 | 39 | 0.350 |
Why?
| Neurofibromatosis 1 | 1 | 2010 | 33 | 0.340 |
Why?
| United States | 8 | 2025 | 5192 | 0.330 |
Why?
| Optic Disk Drusen | 1 | 2009 | 3 | 0.310 |
Why?
| Hemianopsia | 1 | 2009 | 5 | 0.310 |
Why?
| Hydrocephalus | 2 | 2025 | 43 | 0.300 |
Why?
| Cerebrospinal Fluid Shunts | 1 | 2008 | 20 | 0.300 |
Why?
| Dyskeratosis Congenita | 1 | 2008 | 2 | 0.300 |
Why?
| Cerebellum | 2 | 2013 | 125 | 0.290 |
Why?
| Rhombencephalon | 1 | 2007 | 4 | 0.290 |
Why?
| Adrenoleukodystrophy | 1 | 2007 | 2 | 0.290 |
Why?
| Cross-Sectional Studies | 7 | 2025 | 1678 | 0.290 |
Why?
| Botulinum Toxins | 1 | 2007 | 3 | 0.280 |
Why?
| Membrane Proteins | 2 | 2024 | 335 | 0.280 |
Why?
| Visual Pathways | 2 | 2023 | 11 | 0.260 |
Why?
| Aged | 9 | 2025 | 10121 | 0.250 |
Why?
| Fluorescein Angiography | 2 | 2022 | 34 | 0.240 |
Why?
| Retinopathy of Prematurity | 1 | 2025 | 17 | 0.240 |
Why?
| Middle Aged | 9 | 2025 | 13028 | 0.230 |
Why?
| Aortic Aneurysm | 1 | 2025 | 28 | 0.230 |
Why?
| Ventriculoperitoneal Shunt | 1 | 2025 | 29 | 0.230 |
Why?
| Craniocerebral Trauma | 2 | 2023 | 60 | 0.230 |
Why?
| Muscarinic Agonists | 1 | 2024 | 11 | 0.230 |
Why?
| Pilocarpine | 1 | 2024 | 26 | 0.230 |
Why?
| Carotid Stenosis | 1 | 2025 | 66 | 0.230 |
Why?
| Cerebrospinal Fluid Pressure | 2 | 2016 | 3 | 0.230 |
Why?
| Aqueous Humor | 1 | 2024 | 10 | 0.230 |
Why?
| Retinal Artery Occlusion | 1 | 2024 | 13 | 0.230 |
Why?
| Eye Diseases | 1 | 2024 | 29 | 0.220 |
Why?
| Retinal Detachment | 1 | 2024 | 25 | 0.220 |
Why?
| Burns, Chemical | 1 | 2024 | 9 | 0.220 |
Why?
| Consumer Health Information | 1 | 2024 | 19 | 0.220 |
Why?
| Patient Education as Topic | 2 | 2024 | 321 | 0.220 |
Why?
| Intensive Care Units, Neonatal | 1 | 2025 | 135 | 0.220 |
Why?
| Follow-Up Studies | 5 | 2024 | 2279 | 0.220 |
Why?
| Eye Injuries | 1 | 2024 | 24 | 0.220 |
Why?
| Adult | 11 | 2024 | 14161 | 0.210 |
Why?
| Retirement | 1 | 2023 | 14 | 0.210 |
Why?
| Diabetic Retinopathy | 1 | 2024 | 44 | 0.210 |
Why?
| Optic Chiasm | 1 | 2003 | 7 | 0.210 |
Why?
| Optic Atrophy, Hereditary, Leber | 1 | 2003 | 5 | 0.210 |
Why?
| Self Report | 1 | 2024 | 210 | 0.210 |
Why?
| Prevalence | 2 | 2025 | 1006 | 0.200 |
Why?
| Dementia | 1 | 2024 | 134 | 0.200 |
Why?
| Patient Selection | 1 | 2024 | 259 | 0.200 |
Why?
| Retinal Ganglion Cells | 1 | 2022 | 16 | 0.200 |
Why?
| Forecasting | 1 | 2023 | 154 | 0.200 |
Why?
| Young Adult | 5 | 2019 | 4329 | 0.200 |
Why?
| Meningeal Neoplasms | 1 | 2023 | 52 | 0.190 |
Why?
| Charcot-Marie-Tooth Disease | 1 | 2022 | 7 | 0.190 |
Why?
| Central Nervous System Neoplasms | 1 | 2023 | 68 | 0.190 |
Why?
| Optic Atrophy | 1 | 2022 | 16 | 0.190 |
Why?
| Anesthetics, Combined | 1 | 2001 | 2 | 0.190 |
Why?
| Aged, 80 and over | 4 | 2025 | 3392 | 0.190 |
Why?
| Anesthesia, Local | 1 | 2001 | 17 | 0.190 |
Why?
| Proteomics | 1 | 2024 | 329 | 0.180 |
Why?
| Brain Injuries | 1 | 2023 | 159 | 0.180 |
Why?
| Ophthalmoscopy | 2 | 2013 | 15 | 0.180 |
Why?
| Prospective Studies | 4 | 2019 | 2481 | 0.180 |
Why?
| Orbital Diseases | 1 | 2001 | 12 | 0.180 |
Why?
| Macular Degeneration | 1 | 2021 | 28 | 0.180 |
Why?
| Phacoemulsification | 1 | 2001 | 34 | 0.180 |
Why?
| Child Abuse | 1 | 2023 | 140 | 0.180 |
Why?
| Vision Tests | 3 | 2023 | 13 | 0.180 |
Why?
| Anesthetics, Local | 1 | 2001 | 79 | 0.180 |
Why?
| Health Services Accessibility | 1 | 2025 | 436 | 0.180 |
Why?
| Choroiditis | 1 | 2020 | 9 | 0.180 |
Why?
| Socioeconomic Factors | 1 | 2023 | 610 | 0.170 |
Why?
| Multiple Sclerosis | 1 | 2021 | 72 | 0.170 |
Why?
| Health Status Disparities | 1 | 2023 | 215 | 0.170 |
Why?
| Reproducibility of Results | 3 | 2024 | 1229 | 0.170 |
Why?
| Mutation | 3 | 2017 | 1347 | 0.170 |
Why?
| Vitreoretinal Surgery | 1 | 2019 | 8 | 0.160 |
Why?
| Carotid Artery Diseases | 1 | 1999 | 31 | 0.160 |
Why?
| Arteriovenous Fistula | 1 | 1999 | 28 | 0.160 |
Why?
| Crohn Disease | 1 | 2020 | 117 | 0.160 |
Why?
| Healthcare Disparities | 1 | 2023 | 299 | 0.160 |
Why?
| Sensitivity and Specificity | 2 | 2013 | 891 | 0.150 |
Why?
| Laser Therapy | 1 | 2019 | 82 | 0.150 |
Why?
| Retina | 2 | 2024 | 63 | 0.150 |
Why?
| Risk Factors | 4 | 2025 | 3889 | 0.150 |
Why?
| Astigmatism | 1 | 2018 | 5 | 0.150 |
Why?
| Amblyopia | 1 | 2018 | 5 | 0.150 |
Why?
| Imaging, Three-Dimensional | 1 | 2019 | 154 | 0.150 |
Why?
| Mydriatics | 1 | 2018 | 12 | 0.150 |
Why?
| Pupil | 1 | 2018 | 29 | 0.150 |
Why?
| Sinus Thrombosis, Intracranial | 1 | 2018 | 16 | 0.140 |
Why?
| Convergence, Ocular | 1 | 2017 | 2 | 0.140 |
Why?
| Accommodation, Ocular | 1 | 2017 | 3 | 0.140 |
Why?
| Obesity | 3 | 2016 | 1162 | 0.140 |
Why?
| Reading | 1 | 2018 | 73 | 0.140 |
Why?
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 9 | 0.140 |
Why?
| Myopia | 1 | 2017 | 9 | 0.140 |
Why?
| Keratoconus | 1 | 2017 | 4 | 0.140 |
Why?
| Skin Diseases, Genetic | 1 | 2017 | 8 | 0.140 |
Why?
| Heterozygote | 1 | 2017 | 90 | 0.140 |
Why?
| Subarachnoid Hemorrhage | 1 | 2018 | 60 | 0.140 |
Why?
| Minocycline | 1 | 2017 | 15 | 0.140 |
Why?
| Cornea | 1 | 2017 | 53 | 0.140 |
Why?
| Joint Instability | 1 | 2017 | 43 | 0.130 |
Why?
| Arteries | 1 | 2017 | 92 | 0.130 |
Why?
| Equipment Failure | 2 | 2025 | 64 | 0.130 |
Why?
| Carbonic Anhydrase Inhibitors | 1 | 2016 | 5 | 0.130 |
Why?
| Syndrome | 1 | 2017 | 247 | 0.130 |
Why?
| Acetazolamide | 1 | 2016 | 17 | 0.130 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 178 | 0.130 |
Why?
| Depth Perception | 2 | 2005 | 4 | 0.120 |
Why?
| Vascular Malformations | 1 | 2017 | 103 | 0.120 |
Why?
| Nevus of Ota | 1 | 2014 | 2 | 0.120 |
Why?
| Scleral Diseases | 1 | 2014 | 2 | 0.120 |
Why?
| Eye Neoplasms | 1 | 2014 | 8 | 0.120 |
Why?
| Chi-Square Distribution | 2 | 2005 | 288 | 0.120 |
Why?
| Siblings | 1 | 2014 | 34 | 0.110 |
Why?
| Functional Laterality | 1 | 2014 | 90 | 0.110 |
Why?
| Sex Factors | 2 | 2016 | 727 | 0.110 |
Why?
| Treatment Outcome | 3 | 2019 | 5422 | 0.110 |
Why?
| Temporal Arteries | 2 | 2025 | 16 | 0.110 |
Why?
| Cogan Syndrome | 1 | 2013 | 3 | 0.110 |
Why?
| Kidney Diseases, Cystic | 1 | 2013 | 18 | 0.100 |
Why?
| Cerebellar Diseases | 1 | 2013 | 17 | 0.100 |
Why?
| Body Mass Index | 1 | 2016 | 689 | 0.100 |
Why?
| Optic Nerve Neoplasms | 2 | 2004 | 7 | 0.100 |
Why?
| Stroke | 1 | 2018 | 512 | 0.100 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 202 | 0.100 |
Why?
| Case-Control Studies | 2 | 2005 | 1201 | 0.100 |
Why?
| Visual Fields | 2 | 2009 | 41 | 0.100 |
Why?
| Myasthenia Gravis | 1 | 2012 | 19 | 0.100 |
Why?
| Orbit | 2 | 2003 | 26 | 0.100 |
Why?
| Risk Assessment | 1 | 2016 | 1327 | 0.090 |
Why?
| Incidence | 2 | 2025 | 1062 | 0.090 |
Why?
| Anti-Bacterial Agents | 1 | 2017 | 807 | 0.090 |
Why?
| Sex Distribution | 2 | 2024 | 137 | 0.090 |
Why?
| Acute Disease | 2 | 2021 | 373 | 0.080 |
Why?
| Optic Nerve Injuries | 1 | 2009 | 8 | 0.080 |
Why?
| Paranasal Sinuses | 1 | 2009 | 15 | 0.080 |
Why?
| Skin Neoplasms | 1 | 2014 | 505 | 0.080 |
Why?
| Decompression, Surgical | 1 | 2009 | 50 | 0.080 |
Why?
| Endoscopy | 1 | 2009 | 123 | 0.070 |
Why?
| Blood Transfusion | 1 | 2008 | 127 | 0.070 |
Why?
| Tomography, X-Ray Computed | 2 | 2009 | 1165 | 0.060 |
Why?
| DNA, Mitochondrial | 2 | 2003 | 114 | 0.060 |
Why?
| Treatment Failure | 1 | 2025 | 122 | 0.060 |
Why?
| Ophthalmic Solutions | 1 | 2024 | 20 | 0.060 |
Why?
| Age Factors | 2 | 2019 | 1132 | 0.060 |
Why?
| Administration, Topical | 1 | 2024 | 61 | 0.060 |
Why?
| Phosphopyruvate Hydratase | 1 | 2024 | 10 | 0.060 |
Why?
| Vitreous Body | 1 | 2024 | 19 | 0.060 |
Why?
| Paracentesis | 1 | 2024 | 13 | 0.060 |
Why?
| Bone Diseases, Developmental | 1 | 2024 | 17 | 0.060 |
Why?
| Eye Proteins | 1 | 2024 | 16 | 0.060 |
Why?
| Prognosis | 1 | 2010 | 2099 | 0.060 |
Why?
| Methylprednisolone | 2 | 2018 | 41 | 0.060 |
Why?
| Neuronal Ceroid-Lipofuscinoses | 1 | 2004 | 6 | 0.060 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 2004 | 9 | 0.050 |
Why?
| Retinal Degeneration | 1 | 2004 | 9 | 0.050 |
Why?
| Proportional Hazards Models | 1 | 2025 | 443 | 0.050 |
Why?
| Propensity Score | 1 | 2024 | 154 | 0.050 |
Why?
| Vitrectomy | 1 | 2024 | 61 | 0.050 |
Why?
| Refraction, Ocular | 1 | 2023 | 7 | 0.050 |
Why?
| Exons | 1 | 2004 | 102 | 0.050 |
Why?
| Molecular Chaperones | 1 | 2004 | 66 | 0.050 |
Why?
| Cultural Diversity | 1 | 2023 | 36 | 0.050 |
Why?
| Hematoma, Subdural | 1 | 2023 | 14 | 0.050 |
Why?
| Optic Atrophies, Hereditary | 1 | 2003 | 2 | 0.050 |
Why?
| Schools, Medical | 1 | 2023 | 69 | 0.050 |
Why?
| Hypertrophy | 1 | 2003 | 52 | 0.050 |
Why?
| Ischemia | 1 | 2024 | 150 | 0.050 |
Why?
| Chromosome Deletion | 1 | 2004 | 142 | 0.050 |
Why?
| Mass Spectrometry | 1 | 2024 | 292 | 0.050 |
Why?
| Biopsy | 2 | 2021 | 605 | 0.050 |
Why?
| Faculty, Medical | 1 | 2023 | 91 | 0.050 |
Why?
| DNA Mutational Analysis | 1 | 2003 | 180 | 0.050 |
Why?
| Membrane Glycoproteins | 1 | 2004 | 244 | 0.050 |
Why?
| Health Literacy | 1 | 2024 | 132 | 0.050 |
Why?
| Electronic Health Records | 1 | 2024 | 268 | 0.050 |
Why?
| Needlestick Injuries | 1 | 2001 | 2 | 0.050 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2004 | 170 | 0.050 |
Why?
| Pituitary Hormones | 1 | 2001 | 18 | 0.050 |
Why?
| Scotoma | 1 | 2021 | 7 | 0.050 |
Why?
| Vaccination | 1 | 2024 | 298 | 0.050 |
Why?
| Lens Implantation, Intraocular | 1 | 2001 | 23 | 0.050 |
Why?
| Spinal Puncture | 2 | 2018 | 17 | 0.050 |
Why?
| Fundus Oculi | 1 | 2021 | 24 | 0.050 |
Why?
| Bupivacaine | 1 | 2001 | 30 | 0.050 |
Why?
| Lidocaine | 1 | 2001 | 46 | 0.050 |
Why?
| Macrophages | 1 | 2024 | 379 | 0.040 |
Why?
| Mucormycosis | 1 | 2001 | 28 | 0.040 |
Why?
| Graves Disease | 1 | 2001 | 19 | 0.040 |
Why?
| Eye Infections, Fungal | 1 | 2001 | 20 | 0.040 |
Why?
| Pilot Projects | 1 | 2023 | 721 | 0.040 |
Why?
| Intravitreal Injections | 1 | 2020 | 33 | 0.040 |
Why?
| Saccades | 1 | 2000 | 4 | 0.040 |
Why?
| Pedigree | 1 | 2000 | 125 | 0.040 |
Why?
| Aspergillosis | 1 | 2001 | 122 | 0.040 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2020 | 182 | 0.040 |
Why?
| Emergency Service, Hospital | 1 | 2024 | 522 | 0.040 |
Why?
| Angiogenesis Inhibitors | 1 | 2020 | 183 | 0.040 |
Why?
| Trochlear Nerve | 1 | 1999 | 1 | 0.040 |
Why?
| Ophthalmoplegia | 1 | 1999 | 6 | 0.040 |
Why?
| Postoperative Care | 1 | 2019 | 104 | 0.040 |
Why?
| Pandemics | 1 | 2024 | 585 | 0.040 |
Why?
| Cranial Nerve Diseases | 1 | 1999 | 15 | 0.040 |
Why?
| Refractive Errors | 1 | 2018 | 6 | 0.040 |
Why?
| Tropicamide | 1 | 2018 | 5 | 0.040 |
Why?
| Cyclopentolate | 1 | 2018 | 5 | 0.040 |
Why?
| Equipment Design | 1 | 2019 | 293 | 0.040 |
Why?
| Phenylephrine | 1 | 2018 | 34 | 0.040 |
Why?
| Drug Combinations | 1 | 2018 | 132 | 0.040 |
Why?
| Phlebography | 1 | 2018 | 55 | 0.040 |
Why?
| Infant, Newborn | 1 | 2025 | 2867 | 0.040 |
Why?
| Corneal Topography | 1 | 2017 | 6 | 0.040 |
Why?
| Corneal Pachymetry | 1 | 2017 | 5 | 0.040 |
Why?
| Lung Neoplasms | 1 | 2004 | 636 | 0.040 |
Why?
| Dilatation, Pathologic | 1 | 2017 | 26 | 0.040 |
Why?
| Sexual Maturation | 1 | 2016 | 19 | 0.030 |
Why?
| Age Distribution | 1 | 2016 | 174 | 0.030 |
Why?
| Morbidity | 1 | 2016 | 145 | 0.030 |
Why?
| Glucocorticoids | 1 | 2018 | 235 | 0.030 |
Why?
| Disease Progression | 1 | 2018 | 871 | 0.030 |
Why?
| Cytoskeletal Proteins | 1 | 2013 | 48 | 0.030 |
Why?
| Abnormalities, Multiple | 1 | 2013 | 166 | 0.020 |
Why?
| Recovery of Function | 1 | 2009 | 199 | 0.020 |
Why?
| Brain | 2 | 2004 | 1323 | 0.010 |
Why?
| Electroretinography | 1 | 2004 | 16 | 0.010 |
Why?
| Microscopy, Electron | 1 | 2004 | 75 | 0.010 |
Why?
| Neurologic Examination | 1 | 2004 | 73 | 0.010 |
Why?
| Alleles | 1 | 2004 | 276 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 2004 | 461 | 0.010 |
Why?
| Electroencephalography | 1 | 2004 | 312 | 0.010 |
Why?
| Hemorrhage | 1 | 2003 | 209 | 0.010 |
Why?
| Skin | 1 | 2004 | 422 | 0.010 |
Why?
| Muscle, Skeletal | 1 | 2004 | 804 | 0.010 |
Why?
|
|
Phillips's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|